Search Options Stock News and Analysis from Schaeffer's

SEARCH RESULTS FOR: "Tag: XOMA"

REFINE YOUR SEARCH

REFINE YOUR SEARCH:

ARTICLES/BLOGS

2017(1)

2015(2)

CATEGORIES

Analyst Update(1)

Intraday Option Activity(1)

Midday Market Check(1)

Dow Jones Industrial Average Pares Losses; Nasdaq Turns Higher Amid Tech Rally

https://www.schaeffersresearch.com/content/ezines/2017/03/22/dow-jones-industrial-average-pares-losses-nasdaq-turns-higher-amid-tech-rally

3/22/2017 12:04 PM

While the Dow Jones Industrial Average (DJIA) has pared its early losses, stocks are still struggling to make a meaningful move higher ahead of tomorrow's expected House vote on an Obamacare replac...

Analyst Update: Apple Inc., LinkedIn, and XOMA

https://www.schaeffersresearch.com/content/news/2015/10/02/analyst-update-apple-inc-linkedin-corp-and-xoma-corp

10/2/2015 12:15 PM

Analysts are weighing in today on Dow component Apple Inc. (NASDAQ:AAPL), professional social media network LinkedIn Corp (NYSE:LNKD), and drug developer XOMA Corp (NASDAQ:XOMA). Here's a quick roun...

Options Activity Picks Up on XOMA Corporation (XOMA) Drug Data

https://www.schaeffersresearch.com/content/options/2015/05/28/options-activity-picks-up-on-xoma-corporation-xoma-drug-data

5/28/2015 10:40 AM

XOMA Corp (NASDAQ:XOMA) has popped 3% in early trading at $3.42, thanks to encouraging drug trial news. This has the stock's options changing hands at quadruple the expected intraday rate, with calls...

PEOPLE ALSO SEARCH FOR